ArticleJACC. Case reports2026
Mobile Transcatheter Edge-to-Edge Repair Team for Acute Post-Myocardial Infarction Mitral Regurgitation.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Racing the Clock in Cardiogenic Shock: Is Ultra-Early M-TEER Ready?JACC. Case reports · 2026Article
- The Expanding Therapeutic Armamentarium for Mitral Regurgitation: Surgical and Transcatheter Interventions.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiogenic shock (CS) due to papillary muscle rupture causing acute mitral regurgitation (MR) after acute coronary syndrome carries poor prognosis and frequently necessitates urgent MR reduction. CASE SUMMARY: A 70-year-old man presented in CS due to papillary muscle rupture at a hospital without cardiac surgery or expertise in structural heart interventions. He was deemed at high risk for transfer by the heart team, and a percutaneous treatment approach was chosen. A mobile mitral transcatheter edge-to-edge repair (m-TEER) team was dispatched from a tertiary center, and within hours the patient underwent coronary intervention and successful m-TEER, leading to marked hemodynamic and clinical improvement. DISCUSSION: In patients deemed at high risk for transport, a mobile m-TEER service ensures procedural safety and quality while avoiding the hazards of interfacility transport. TAKE-HOME MESSAGE: A mobile m-TEER team can deliver effective m-TEER for patients in CS requiring urgent MR reduction and deemed at high risk for transfer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.